Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154669 | SCV000204347 | benign | not specified | 2012-02-02 | criteria provided, single submitter | clinical testing | Inferred frequency = 273/386 (LMM data) |
Eurofins Ntd Llc |
RCV000154669 | SCV000231907 | benign | not specified | 2014-08-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001511033 | SCV001158870 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001511033 | SCV001718207 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001532780 | SCV001748492 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154669 | SCV003928749 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453162 | SCV004181971 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888600 | SCV004707264 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001511033 | SCV005287606 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001532780 | SCV002088294 | benign | Usher syndrome type 2A | 2019-11-18 | no assertion criteria provided | clinical testing |